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Merel E. Valk-Lingbeek, Sophia W.M. Bruggeman,
and Maarten van Lohuizen*
The Netherlands Cancer Institute
Department of Molecular Genetics saka et al., 2001; Core et al., 1997; Takihara et al., 1997).
An exception to this rule is Rnf2 deficiency, resulting inPlesmanlaan 121
1066 CX Amsterdam an early lethal phenotype similar to PRC2-deficient mice
(Voncken et al., 2003).The Netherlands
However, the existence of only two PcG complexes
is an oversimplification, as recent evidence in flies and
mammals indicates that heterogeneous protein com-
plexes of varying composition can be formed even withinProteins from the Polycomb group (PcG) are epige-
netic chromatin modifiers involved in cancer develop- one cell (reviewed in Lund and van Lohuizen, 2004). For
instance, Ezh2 can associate with different isoforms ofment and also in the maintenance of embryonic and
adult stem cells. The therapeutic potential of stem Eed thereby determining the specificity of the histone
methyltransferase activity, i.e., toward histone H3 lysinecells and the growing conviction that tumors contain
stem cells highlights the importance of understanding 27 or histone H1 lysine 26 (Kuzmichev et al., 2004). This
recent finding is intriguing given the important role ofthe extrinsic and intrinsic circuitry controlling stem
cell fate and their connections to cancer. H1-linker histones in mediating higher order chromatin
folding. Furthermore, PcG complexes are regulated in
a cell cycle-dependent manner, necessary to ensure
that chromatin marks are correctly reset upon DNA repli-The Polycomb Group (PcG) gene family is highly con-
served throughout evolution. Originally, PcG genes were cation (Voncken et al., 1999; Akasaka et al., 2002). Lastly,
posttranslational modifications influence localization anddiscovered in Drosophila as repressors of Homeotic
genes, which are necessary for establishment of the activity of PcG (Voncken et al., 1999; Akasaka et al.,
2002). Clearly, PcG proteins and PcG complex composi-body plan and segmentation. Also in mammals, PcG
genes are implicated in Homeobox (Hox) gene regula- tion are highly regulated in a dynamic and complicated
manner allowing for gene, tissue, and differentiationtion. Their biological activity lies in stable silencing of
specific sets of genes through chromatin modifications. stage-specific function.
This capacity makes them interesting subjects for stem
cell research, since it is conceivable that dynamic repro- Setting the Stage: Role for PcG Genes
gramming of cells, for instance during differentiation, in Stem Cells
requires alterations in the epigenetic state of gene ex- Stem cells are defined as cells able to both extensively
pression programs. self-renew and differentiate into progenitors. Embryonic
Two distinct multiprotein PcG complexes have been stem (ES) cells and embryonic germ cells are said to be
identified (reviewed in Lund and van Lohuizen, 2004; and pluripotent because they can give rise to all cell types
see Table 1 for names and corresponding Drosophila of the embryo proper. Adult or somatic stem cells (SSCs)
counterparts). Polycomb repressive complex 2 (PRC2) often are multi- or oligopotent, indicating they can give
is involved in the initiation of silencing and contains rise to a subset of cell lineages, or unipotent, when they
histone deacetylases and histone methyltransferases, only contribute to one type of mature cells. Stem cells
that can methylate histone H3 lysine 9 and 27, marks are believed to reside in many, if not all, adult tissues,
of silenced chromatin, and histone H1 lysine 26 (van der and have been well described for intestine, skin, muscle,
Vlag and Otte, 1999; Cao et al., 2002; Czermin et al., blood, and nervous system. Notably, it is not only intrin-
2002; Muller et al., 2002; Kuzmichev et al., 2004). Dele- sic properties that determine stem cell fate: extrinsic
tion of PRC2 genes in mice results in early embryonic cues given by the stem cell “niche” are at least of
lethality, underscoring their importance in development equal importance.
(Schumacher et al., 1996; O’Carroll et al., 2001). Poly- Recent results highlight that stem cell fate is in part
comb repressive complex 1 (PRC1) is implicated in sta- governed by the PcG genes. First indications came from
ble maintenance of gene repression and recognizes, by Bmi1-deficient mice, which suffer from progressive loss
means of a chromodomain, the H3 lysine 27 mark set of hematopoietic cells and cerebellar neurons (van der
by PRC2 (Czermin et al., 2002). Its precise in vivo mode Lugt et al., 1994). In addition, Mph1/Rae28, which di-
of action is not completely understood, but in vitro it is rectly interacts with Bmi1 in the PRC1 complex, is re-
found to interact with histone methyltransferases, his- quired for sustaining activity of hematopoietic stem cells
tones, and to counteract SWI/SNF-chromatin-remodel- (Ohta et al., 2002). Over the last year, direct evidence
ing complexes (Breiling et al., 1999; Levine et al., 2002; implicated Bmi1 in the self-renewal of multiple stem cells
Ogawa et al., 2002; Sewalt et al., 2002). Recent evidence as well as the proliferation of early cerebellar progenitors
in Drosophila suggests that PcG inhibits the transcrip- (Lessard and Sauvageau, 2003; Molofsky et al., 2003;
tion initiation machinery (Dellino et al., 2004; Wang et Park et al., 2003; Leung et al., 2004). Importantly, in
the cerebellum, Bmi1 is regulated by an extracellular-
signaling molecule, the morphogen Sonic hedgehog*Correspondence: m.v.lohuizen@nki.nl
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Table 1. Polycomb Nomenclature
Drosophila proteins Human proteins Mouse proteins
PRC2/Initiation complex
Esc Extra sex combs EED Eed
E(z) Enhancer of Zeste EZH1 Ezh1/Enx2
EZH2 Ezh2/Enx1
Su(z)12 Suppressor of Zeste 12 SUZ12
PRC1/Maintenance complex
Pc Polycomb CBX2/HPC1 Cbx2/M33
CBX4/HPC2 Cbx4/Mpc2
CBX8/HPC3
Ph Polyhomeotic EDR1/HPH1 Edr1/Mph1/Rae28
EDR2/HPH2 Edr2/Mph2
EDR3/HPH3
dRING RING1/RNF1/RING1A Ring1/Ring1a
RNF2/RING1B Rnf2/Ring1b
Psc Posterior sex combs BMI1 Bmi1
RNF110/ZFP144 Rnf110/Zfp144/Mel-18
ZNF134 Znf134/Mblr
Pho Pleiohomeotic YY1 Yy1
Pho-like Pleiohomeotic-like
Scm Sex combs on midleg SCML1 Scmh1
SCML2 Scmh2
Pcl Polycomb-like PHF1
(Shh) (Leung et al., 2004), providing for the first time a stages in chimeras, indicating partial noncell autono-
mous rescue of Eed deficiency in vivo (Morin-Kensickiconnection between PcG and a major developmental-
signaling pathway. This connection may only be the et al., 2001). It is formally possible that early in develop-
ment, Ezh2 functions independently of Eed in the PRC2beginning of our understanding of how complex mecha-
nisms, required for embryogenesis and stem cell behav- complex. Alternatively, the Eed mutant may not repre-
sent a null allele, especially since Eed appears to beior, are organized.
required for the ability of Ezh2 to methylate histone H3
(Cao et al., 2002). Furthermore, both Eed and Ezh2 be-PcG and Embryonic Stem Cells
come transiently localized to the inactive X during ESES cells can be viewed as the “mother” of all stem cells.
cell differentiation, and most importantly, in Eed-defi-They possess the unique capacity to undergo efficient
cient cells X inactivation is not maintained (Plath et al.,and remarkably robust self-renewal in cell culture, and
2003; Silva et al., 2003).even upon prolonged culturing they retain the ability to
The crucial role of PRC1 member Rnf2 in develop-undergo multiple differentiation pathways. When placed
ment, for which Ring1a cannot compensate, suggestsback in their own “niche” upon injection into blastocysts,
either a central role in complex formation for Rnf2, orES cells resume normal behavior and contribute faith-
the requirement of a transient contact between PRC1fully to all cell lineages. Under carefully controlled tissue
and PRC2 via Rnf2 as described for Drosophila (Francisculture conditions, it was found that cell-extrinsic sig-
et al., 2001; Poux et al., 2001). Another PRC1 protein,nals, such as LIF and BMP4, regulate the self-renewal
Mph1/Rae28, is highly expressed in ES cells but be-of ES cells. Cell-intrinsic signaling involves the concomi-
comes rapidly downregulated upon differentiation (Lor-tant receptors and signals down to transcription factors,
ing et al., 2001; Fortunel et al., 2003). It is clear thatsuch as Oct4 and Nanog (Niwa et al., 2000; Chambers
Polycomb silencing early in development needs bothet al., 2003; Ying et al., 2003). These pathways are not
complexes, however, the precise mode of action needsyet fully understood, but PcG proteins might participate
more investigation.at some level considering that Ezh2, Eed, YY1, and Rnf2
all are essential for embryonic development (Schu-
macher et al., 1996; Donohoe et al., 1999; O’Carroll et PRC1 PcG Genes Bmi1, Mph1/Rae28, and Mel-18
Regulate the Self-Renewal of Hematopoietical., 2001; Voncken et al., 2003). Ezh2 and Rnf2 expres-
sion can be detected early in development at preimplan- Stem Cells
Hematopoiesis in mammals occurs in distinct temporaltation stages, whereas robust Eed expression com-
mences after implantation (Schumacher et al., 1996; waves shifting from the extraembryonic yolk sac and
fetal liver in embryos to bone marrow in adults. DefinitiveO’Carroll et al., 2001; Voncken et al., 2003). In vitro,
Ezh2-deficient blastocysts fail to grow out and Ezh2- hematopoietic stem cells (HSCs) replenish the pool of
blood cells both by maintaining the stem cells and bydeficient ES cell lines cannot be established (O’Carroll
et al., 2001). In contrast, Eed mutant ES cells are viable allowing daughter cells to differentiate into the lymp-
hoid, myeloid, and erythroid lineages. The stem celland can in the context of embryoid bodies differentiate
into multiple cell types. Interestingly, Eed mutant ES niche in the bone marrow provides the cells with a spe-
cialized extracellular matrix secreted by a number ofcells can also contribute to more advanced embryonic
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different cell types. An array of extracellular signaling These results suggest differential functions for PcG pro-
teins in the control of hematopoietic cell proliferation:pathways, such as Notch, BMP, JAK-STAT, and Wnt
control hematopoietic stem cells (reviewed in Fuchs et a negative function for PRC2-Eed containing complexes
and a positive function for PRC1-Bmi1-Mph1/Rae28-al., 2004). However, relatively little is known about cell-
intrinsic genetic and epigenetic mechanisms. containing complexes. Since Eed and Bmi1 are involved
in distinct complexes and at least in Drosophila autoreg-Expression of most PcG genes is upregulated in differ-
entiating hematopoietic cells (Raaphorst et al., 2001), ulation loops exist, loss of Eed might lead to an overre-
presentation of the Bmi1-Mph1/Rae28-containing stim-but Bmi1 and Mph1/Rae28 are highly expressed in primi-
tive hematopoietic cells (Ohta et al., 2002; Park et al., ulatory complexes, ultimately resulting in hematopoietic
overproliferation.2003). Most compelling, Bmi1, Mel-18, Mph1/Rae28,
and M33 mutant mice suffer from various defects in the
hematopoietic system, such as hypoplasia in spleen and Bmi1 Is Necessary for Neural Stem Cell Renewal
thymus, reduction in overall T cell numbers, defects in and Early Neural Progenitors
B cell development, and an impaired proliferative re- Throughout adult life, two major neurogenic regions per-
sponse of lymphoid precursors to cytokines, in particu- sist: the subventricular zone (SVZ) of the lateral ventricle
lar to interleukin 7 (IL-7) (van der Lugt et al., 1994; Aka- wall and the subgranular zone of the hippocampus
saka et al., 1997, 2001; Core´ et al., 1997; Takihara et (Doetsch, 2003). With appropriate growth factors, cul-
al., 1997). tured neural stem cells (NSCs) grow as adherent colo-
Close inspection of fetal HSC pools revealed interest- nies or as “neurospheres,” floating clusters of stem cells
ing differences and similarities between Bmi1-, Mel-18-, and their progenitors. The precise cellular origin of neu-
and Mph1/Rae28-deficient mice. Whereas fetal liver- ral stem cells and the nature of neurospheres in vitro is
derived HSCs (FL-HSCs) are present in normal numbers a subject of controversy. Accumulating evidence sup-
in Bmi1-deficient mice, the number of FL-HSCs from ports that in vivo, NSCs are astrocyte-like, glial fibrillary
Mph1/Rae28-deficient mice progressively decreases acidic protein (GFAP)-positive cells (Doetsch et al., 1999,
from E14.5 onward (Ohta et al., 2002; Park et al., 2003). Seri et al., 2001; Imura et al., 2003). However, in vitro
However, both Bmi1- and Mph1/Rae28-deficient FL- neurospheres can also be derived from more mature
HSCs are impaired in their proliferative and self-renewing transit-amplifying cells (Doetsch et al., 2002).
capacity as was assessed in vitro and in vivo. (Ohta et Prospective defects in the stem cell compartment of
al., 2002; Lessard and Sauvageau, 2003; Park et al., the nervous system of Bmi1-deficient mice could be
2003). In the adult mouse, Bmi1-deficient HSCs are deduced from their neurological phenotype (van der
found less frequent and display strong defects in prolif- Lugt et al., 1994). The main problem appears to lie in
eration and self-renewal. However, they do give rise to the cerebellum, which is reduced in size due to severe
a normal number of multipotent progenitors, suggesting loss of both molecular and granular layer neurons. Occa-
that in vivo, the loss of stem cells is compensated by sionally, degenerated neurons can be observed in the
an increased formation of their immediate descendants hippocampus, as well as extensive gliosis of the major
(Park et al., 2003). Curiously, loss of Mel-18, a homolog of white matter tracts. Strikingly, Bmi1-deficient mice be-
Bmi1, appears to enhance HSC self-renewal suggesting come depleted of cerebral NSCs postnatally, indicating
that the relative levels of a constituent in the complex an in vivo requirement for Bmi1 in NSC renewal (Molof-
dictate HSC self-renewal capacity (Kajiume et al., 2004). sky et al., 2003). In contrast to the cerebellum, cerebral
Analogous to B cell defects in PcG mutants resulting in development is largely completed around time of birth.
part from unresponsiveness to IL-7, Bmi1, and Mph1/ An intriguing possibility therefore is that similar to fetal
Rae28 self-renewal defects might reflect a poor re- versus adult hematopoietic stem cells, neurogenesis
sponse of mutant HSCs to stem cell growth factors. during embryogenesis might be under separate control
As to the differences between Bmi1- and Mph1/Rae28- from that of adult NSCs and cerebellar progenitor cells,
deficient HSCs, it is likely that fetal and adult HSCs are allowing “normal” development prebirth. Another possi-
regulated by different signals and mechanisms, only the bility is that in response to stem cell depletion, progeni-
latter of which requires Bmi1. tors receive signals from the niche that instruct them to
“reprogram” their gene expression profile and become
committed to an unfamiliar compensatory task. In lineUnexpected Functions for PRC2 PcG Genes
in Hematopoietic Cells with this, Bmi1-deficient committed progenitors are
present at normal frequencies and proliferate at a similarAnother question is whether PRC2 is also involved in
HSC function. Panhematopoietic ablation of Ezh2 re- rate as wild-type progenitor colonies (Molofsky et al.,
2003).vealed a block in early B cell differentiation, but no obvi-
ous effects on other lineages (Su et al., 2003). Perhaps A clue as to which cell-extrinsic signals modulate PcG
function in the nervous system came from a study ofEzh2 is not required for normal HSC function, which
would be remarkable since Ezh2 function is indispens- cerebellar granule neuron progenitors (CGNPs). Devel-
opment of the cerebellum is guided by Purkinje cellable for ES cells. A more trivial explanation though is
functional redundancy by Ezh1 (Su et al., 2003). excreted Shh, which drives a postnatal wave of prolifera-
tion of CGNPs in the external granular layer (EGL). InSurprisingly, Eed heterozygous or hypomorphic ani-
mals display a myeloid and lymphoid overproliferation time, these cells become postmitotic, migrate inward,
and differentiate into cerebellar granule neurons (Gol-phenotype (Lessard et al., 1999). Furthermore, they have
an increased incidence and decreased latency of chemi- dowitz and Hamre, 1998). At the molecular level, Shh
acts by binding to its receptor, Patched (Ptch), releasingcal-induced thymic lymphoma (Richie et al., 2002).
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Other PcG Genes in the Nervous System
Studying the effects of PRC2 members on neurogenesis
is complicated due to early embryonic lethality of knock-
out mice (Schumacher et al., 1996; Donohoe et al., 1999;
O’Carroll et al., 2001). However, a subset of embryos
heterozygous for YY1 displays neural tube defects re-
sembling exencephaly, pointing to a role for YY1 in
nervous system development (Donohoe et al., 1999).
Interestingly, in chimeras with Eed-deficient cells, con-
tribution to the forebrain appears to be specifically re-
duced (Morin-Kensicki et al., 2001). For other PRC1
members, a function in NSC renewal has not yet been
reported despite high expression of several PcG genes
in the developing nervous system (Akasaka et al., 2001;
Schoorlemmer et al., 1997). This is most remarkable for
Mel-18, which can compensate for Bmi1 deficiency in
many other organs, suggesting a high degree of func-
tional specification between these recently diverged
PcG genes. (Akasaka et al., 2001). The Bmi1 cerebellar
phenotype becomes more aggravated in Bmi1; Rnf2
doubly deficient compound mice (Voncken et al., 2003),
showing synergistic interactions between these two
PRC1 proteins in the nervous system. Notably, defi-
ciency of Mph1/Rae28 leads to ocular abnormalities and
malformations of neural-crest-derived tissues (Takihara
et al., 1997). This is intriguing, since Mph1/Rae28 is
essential for renewal of HSCs and is highly expressedFigure 1. Working Model of Bmi1 in the Shh Pathway in Cerebel-
in ES cells (Loring et al., 2001; Ohta et al., 2002; Fortunellar Progenitors
et al., 2003). It is plausible that, analogous to the situationBmi1 acts as a downstream effector of Shh signaling, required for
with Bmi1, Mph1/Rae28 functions in NSC renewal asfull proliferation/self-renewal of cerebellar progenitor cells, in com-
bination with activation of N-myc/CyclinD2. Thus, Shh is able to well.
modulate both pRb (via N-myc and Bmi1/p16Ink4a) and p53 (via Bmi1/
p19Arf). In addition, the involvement of other targets important in
The Tumor Suppressor Locus Ink4a/Arfcerebellar biology remains a possibility (Shh, Sonic Hedgehog;
Is an Important PcG Target in Stem CellsPTCH, Patched; SMOH, Smoothened).
Bmi1 is a potent negative regulator of the Ink4a/Arf locus
in mouse embryonic fibroblasts (Jacobs et al., 1999).
This locus encodes the cell cycle regulators and tu-
the inhibition of Ptch on the transmembrane protein
mor suppressors p16Ink4a and p19Arf (p14ARF in humans).
Smoothened (Figure 1). This ultimately results in down- p16Ink4a affects the retinoblastoma protein pRb by inhib-
stream signaling in the nucleus by Gli transcription fac- iting the cyclin D-Cdk4/6 kinase complexes. Hypophos-
tors (Rubin and Rowitch, 2002; Pasca di Magliano and phorylated pRb will sequester E2F transcription factors
Hebrok, 2003). Proliferation of CGNPs in vitro can be and actively repress their target genes, ultimately lead-
induced by Shh and is accompanied by induction of ing to cell cycle arrest, senescence, or apoptosis de-
N-myc, cyclin D1 and D2, in agreement with the ob- pending on context (reviewed in Sharpless and DePinho,
served defects in EGL of mice deficient for these genes 1999). p19Arf binds MDM2 and thereby inhibits degrada-
(Ciemerych et al., 2002; Knoepfler et al., 2002; Kenney tion of the p53 transcription factor. This results in activa-
et al., 2003). It was found that Bmi1-deficient CGNPs tion of p53 target genes, leading to cell cycle arrest
have an impaired proliferative response upon Shh stimu- and apoptosis (reviewed in Lowe and Sherr, 2003). Both
lation. Importantly, in the same cells, Bmi1 expression p16Ink4a and p19Arf expression can be induced by aberrant
can be induced by both Shh and Gli1 (Leung et al., 2004). mitogenic or oncogenic signaling, as well as upon tissue
These findings explain the reduced number of cerebellar culture stress, thus functioning as a potent fail-safe
granule neurons in Bmi1-deficient mice as a result of mechanism preventing cells from engaging in uncon-
an attenuated Shh response due to lack of one of its trolled proliferation.
downstream targets, Bmi1 (Figure 1). Notably, in both Analogous to the situation in fibroblasts, in neural
hippocampal progenitors and SVZ neural stem cells, and hematopoietic stem cells lacking Bmi1, p16Ink4a, and
Shh is important for proliferation and renewal (Lai et al., p19Arf are upregulated (Molofsky et al., 2003; Park et
2003; Machold et al., 2003). Moreover, hematopoietic al., 2003). Conversely, Bmi1; Ink4a/Arf doubly deficient
stem cells are regulated by this signaling route as well. animals display a substantial rescue of the stem cell
Indian hedgehog, another member of the Hh family, acti- defects, as indicated by restored lymphocyte counts
vates hematopoiesis whereas Shh influences the prolif- and normal cerebellar size (Jacobs et al., 1999). In neu-
eration of HSCs (Bhardwaj et al., 2001; Dyer et al., 2001). rosphere assays, loss of p16Ink4a alone in Bmi1-deficient
Whether Bmi1 is an Hh target in other cell types and NSCs partially rescues self-renewal capacity, suggesting
that also p19Arf may additionally help to limit the self-tissues awaits further investigation.
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renewal of these cells (Molofsky et al., 2003). Since the which contain more Bmi1 and are therefore capable of
Ink4a/Arf locus strongly responds to tissue culture keeping Ink4a/Arf levels in check.
stress, careful in vivo analysis is needed to firmly estab-
lish the relative contribution of these proteins to the Are Hox Genes Implicated as PcG
Bmi1-deficient phenotype. Nevertheless, the emerging Targets in Stem Cells?
role for this locus in restricting the potentially dangerous The skeletal defects of PcG mutant mice revealed PcG
self-renewal divisions of stem cells through control of genes as Hox gene regulators (van der Lugt et al., 1994).
PcG signaling is an exciting connection. In line with PcG Hox genes also determine cell fate in several other tis-
proteins acting in multiprotein complexes, additional sues. Hoxa5, Hoxa9, Hoxa10, Hoxb3, Hoxb4, and Hoxb6
PcG members regulate Ink4a/Arf, such as Mel-18 and are important in HSCs (Owens and Hawley, 2002). For
Cbx7 (Jacobs et al., 1999; Gil et al., 2004). Further, the instance, Hoxb4 overexpression enhances the self-
developmental arrest of Rnf2-deficient embryos is ac- renewal of HSCs (Antonchuk et al., 2002). Reciprocally,
companied by an upregulation of p16Ink4a and is partially Hoxb4-deficient mice have disturbed hematopoiesis
bypassed in an Ink4a/Arf-deficient background (Von- (Bjornsson et al., 2003). Extrapolating from their classi-
cken et al., 2003). cal role in axial patterning, a simple view could be that
There is additional evidence supporting a more gen- PcG proteins repress Hox genes in differentiated hema-
eral function for Ink4a/Arf in stem cells. First, enforced topoietic cells. Remarkable in that respect, expression
expression of p16Ink4a or p19Arf in normal HSCs results in of a panel of relevant Hox genes was not altered in
proliferative arrest or p53-dependent cell death, respec- the hematopoietic organs of Eed, Bmi1, or Mph1/Rae28
tively (Park et al., 2003). Second, Ink4a/Arf-deficient mutant mice (Lessard et al., 1999; Ohta et al., 2002;
bone marrow cells proliferate better than wild-type cells Lessard and Sauvageau, 2003). In contrast, Bmi1 regu-
in tissue culture assays (Lewis et al., 2001), although lates three Hox genes in NSCs: Hoxd8, Hoxd9, and
in vivo reconstitution assays have not been reported as Hoxc9 (Molofsky et al., 2003). In vivo, Hox genes coordi-
of yet. Still, it is clear that stem cell-cycle control does nate the patterning of the nervous system by influencing
not entirely depend on this locus, as the Ink4a/Arf-defi- motor neuron diversification in the hindbrain and spinal
cient mouse appears relatively normal. This suggests cord (reviewed in Guthrie, 2004), though no robust ex-
the existence of multiple additional levels of regulation. pression has been described in NSCs (Santa-Olalla et
Indeed, the cell cycle inhibitors p21Cip1 and p18Ink4c have al., 2003). Possibly, loss of Bmi1 induces loss of the
already been reported to control stem cell proliferation undifferentiated nature of NSCs, as reflected by reacti-
(Cheng et al., 2000a; Yuan et al., 2004). Another cell cycle vated Hox gene expression.
inhibitor, p27Kip1, affects proliferation of progenitors both
in the hematopoietic system and the cerebellum (Cheng Self-Renewal Capacity of Cancer Stem Cells
et al., 2000b; Miyazawa et al., 2000). An important future Is Regulated by Bmi1
goal will be to unravel the relative contribution of the The hypothesis that cells with stem cell characteristics
different cell cycle inhibitors to stem cell proliferation or “cancer stem cells” (CSCs) “drive” cancer prolifera-
and their respective regulatory cascades.
tion and progression is receiving increasing support.
It is important to mention the profound differences in
This hypothesis offers an explanation for the extensive
cell cycle regulation between stem cells early in develop-
proliferative capacity of tumor cells, resembling self-
ment versus adult stem cells or differentiated cells. This
renewal of stem cells. In addition, it explains at least inis best exemplified in ES cells, which have a very short
part why tumors often consist of heterogeneous cellG1 phase with almost undetectable levels of hypophos-
populations: a small proportion of proliferating stemphorylated pRb (reviewed in Burdon et al., 2002). In
cells and a majority representing differentiated daughteraddition, ES cells do not arrest upon p16Ink4a overexpres-
cells. Stem cells also form attractive candidates as thesion. Furthermore, p53 remains largely cytoplasmic and
origin of cancers, as in their long lifespan mutations andappears not to participate in DNA damage responses
epigenetic changes can accumulate allowing increasingin ES cells. Ezh2 was postulated to regulate rapid cell
evolution toward malignancy. Indeed, only a small per-proliferation during the transition from pre- to postim-
centage of leukemic cells in patients have strong prolif-plantation stages (O’Carroll et al., 2001). Since it is un-
erative capacity. Moreover, a small subpopulation oflikely that defects in Ezh2-deficient blastocysts result
acute myeloid leukemia (AML) cells was able to give risefrom Ink4a/Arf deregulation, there must be other as yet
to leukemia in secondary recipients. This subpopulationunknown PcG targets important in ES cells.
could be identified using surface markers and theseThe best argument that not all PcG defects are associ-
leukemic stem cells turned out to closely resemble hu-ated with Ink4a/Arf deregulation is probably the incom-
man hematopoietic stem cells (Lapidot et al., 1994; Bon-plete rescue of multiple defects in Bmi1-deficient mice
net and Dick, 1997). Recently, cancer stem cells wereupon loss of the Ink4a/Arf locus (Jacobs et al., 1999).
also found to reside within solid tumors including severalAlso, EZH2 knockdown in fibroblasts does not upregu-
types of brain cancers (Hemmati et al., 2003; Singh etlate p14ARF levels (Bracken et al., 2003). Furthermore,
al., 2003) and breast carcinomas (Al-Hajj et al., 2003).Ink4a/Arf expression is not altered in the hematopoietic
To date, it remains difficult to determine whether asystem of Eed mutant mice (Lessard et al., 1999), and
cancer stem cell indeed is derived from a somatic stemmoreover, p16Ink4a or p19Arf expression is not altered in
cell, from a (de)differentiated progenitor or even a termi-E14.5 Mph1/Rae28-deficient FL-HSCs (Ohta et al.,
nally differentiated cell. Notably, in vitro mature Ink4a/2002). The stoichiometry of early acting PcG complexes,
Arf-deficient astrocytes can regain neural stem cell-likewhich are relatively abundant in Mph1/Rae28, likely dif-
fers from the complexes found later in development, characteristics upon activated epithelial growth factor
Cell
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(EGF) signaling (Bachoo et al., 2002). Moreover, these
cells cause glioblastoma multiforme when injected into
the brains of recipient mice, illustrating their functional
dedifferentiation. Additionally, somatic cell nuclear trans-
fer experiments highlight a remarkable reprogramming
capacity, not only of “normal” cell nuclei but also of
cancer cell-derived nuclei, such as from medulloblas-
toma or melanoma (Li et al., 2003; Eggan et al., 2004).
This illustrates that apart from genetic lesions, epige-
netic processes by and large dictate (de)differentiation
processes, which opens the challenge to identify the
relevant players.
The Bmi1 PcG gene was originally identified as an
oncogene inducing B or T cell leukemia (Haupt et al.,
1991; van Lohuizen et al., 1991). BMI1 is overexpressed
in several human cancers, including mantle cell lym-
phoma, colorectal carcinoma, liver carcinomas, and Figure 2. Speculation of How the Niche or Extrinsic Signals Can
nonsmall cell lung cancer (Bea´ et al., 2001; Vonlanthen at Least in Part Regulate “Stemness” by Governing Intrinsic Cell
Cycle Regulatorset al., 2001; Kim et al., 2004; Neo et al., 2004). Recent
studies showed elegantly that Hoxa9-Meis1-transduced Wnt is in intestine known to regulate p21Cip1 via c-Myc, however
possible links with PcG proteins have also been suggested (seecells of Bmi1-deficient mice were able to generate AML
text). Shh regulates the PcG complex by increasing Bmi1 levels,in primary recipients, but unlike wild-type-derived AML
thereby possibly influencing the p16Ink4a and p19Arf cell cycle inhibi-cells, failed to reform AML in secondary recipients (Les-
tors. For other niche signals (such as Notch or BMP) and cell cycle
sard and Sauvageau, 2003). Additionally, Bmi1-deficient inhibitors (such as p18Ink4c), no such relationships have been de-
hematopoietic progenitors are resistant to transforma- scribed as yet.
tion by the chimeric oncogene E2a-Pbx1, a translocation
frequently found in acute human pre-B lymphoblastic
leukemias (Smith et al., 2003). Interestingly, overexpres- more primitive malignant cell types, often in combination
sion of E2a-Pbx1 induces Bmi1, providing an alternative with high BMI1 expression (Raaphorst et al., 2001).
way of Ink4a/Arf suppression. This may explain the se- Whether high PcG expression reflects the acquirement
lective absence of loss-of-function mutations of the of stem cell-like properties and/or influences the self-
Ink4a/Arf locus in leukemias with E2a-Pbx1 transloca- renewal of cancer stem cells remains to be elucidated.
tions. Furthermore, cancer stem cells cultured from a In prostate cancer, high EZH2 expression is indicative
panel of pediatric brain tumors showed high expression of a metastatic character of the disease and knockdown
of Bmi1 among other stem cells markers (Hemmati et of EZH2 in prostate cancer cell lines causes a marked
al., 2003). Finally, Bmi1 is overexpressed in a majority inhibition of cell growth (Varambally et al., 2002). In vitro,
of medulloblastomas, tumors believed to arise from un- Ezh2 is capable of acting as an oncogene and can be
controlled proliferating cerebellar granule cell precur- induced by the E2F transcription factors. Curiously,
sors (Leung et al., 2004). It is possible that overexpres- Ezh2 expression is not cell cycle regulated (Bracken
sion of Bmi1 not only stimulates rapid proliferation et al., 2003). Furthermore, the marked growth arrest of
through repression of the Ink4a/Arf locus, but, reflecting U2OS tumor cell line upon EZH2 depletion suggests a
its function in neural stem cells, also allows the CGNPs far more drastic effect than cell cycle deregulation via
to “return to” or maintain a more stem cell-like state. INK4a/ARF or p53 only.
Interestingly, in line with the role of Bmi1 in proliferation Another component of PRC2, SU(Z)12, is upregulated
of CGNPs downstream of Shh, overexpression was in human colon and breast tumors (Kirmizis et al., 2003).
found in those medulloblastomas harboring activated Interestingly, the promoter of SU(Z)12 can be bound by
Shh signaling (Leung et al., 2004). In addition to contrib- -catenin/TCF complexes, downstream targets of Wnt
uting to medulloblastoma, misregulation of Shh signal- signaling. Wnt signaling is essential for stem cell activity
ing plays a role in multiple types of cancers with pre- in various tissues, such as the hematopoietic system,
sumed cancer stem cell characteristics, including basal skin, and intestine (Fuchs et al., 2004). Although highly
cell carcinoma, pancreatic adenocarcinoma, and small- speculative, it is possible that in skin and intestine and
cell lung carcinoma (reviewed in Pasca di Magliano and in cancers derived therefrom, PcG could be linked to
Hebrok, 2004). It will be important to assess if also in another important developmental signaling pathway,
these cancers a connection between Bmi1 and Shh such as Wnt, through PRC2.
exists.
Concluding Remarks
It seems reasonable to designate at least the PRC1Prospective Roles for Other PcG Genes
in Cancer Stem Cells gene Bmi1, and probably also Mph1/Rae28, as genes
intrinsically conferring stem cell characteristics to a cell.PRC2 members are also associated with cancer. EZH2 is
upregulated in many cancers such as leukemia, prostate However, there is some debate whether such uniformly
acting “stemness genes” exist at all, since the searchcancer, and breast cancer (Raaphorst et al., 2001; Vara-
mbally et al., 2002; Bracken et al., 2003; Kleer et al., for a stem cell “molecular signature” by comparing the
transcriptional profiles of several stem cells and progen-2003). Interestingly, high EZH2 expression localizes to
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